These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2818908)

  • 1. [The observation of blood-brain barrier of organic mercury poisoned rat: a Gd-DTPA enhanced magnetic resonance study].
    Kuwabara T; Yuasa T; Hidaka K; Igarashi H; Kaneko K; Miyatake T
    No To Shinkei; 1989 Jul; 41(7):681-5. PubMed ID: 2818908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of Gd-DTPA on magnetic resonance imaging: a potential blood-brain barrier indicator].
    Hashimoto K; Yamagata S; Minamikawa J; Watanabe Y; Kanesiro M; Kikuchi H
    No To Shinkei; 1988 May; 40(5):461-6. PubMed ID: 3415864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-time monitoring of gadolinium diethylenetriamine penta-acetic acid during osmotic blood-brain barrier disruption using magnetic resonance imaging in normal wistar rats.
    Blanchette M; Pellerin M; Tremblay L; Lepage M; Fortin D
    Neurosurgery; 2009 Aug; 65(2):344-50; discussion 350-1. PubMed ID: 19625914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood-brain barrier injury following intracarotid injection of radiographic contrast media. In vivo quantification using magnetic resonance imaging and Gd-DTPA.
    Hayakawa K; Yamashita K; Mitsumori M; Nakano Y
    Acta Radiol; 1990 Mar; 31(2):203-8. PubMed ID: 2372465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative evaluation of blood-cerebrospinal fluid barrier permeability in the rat with experimental meningitis using magnetic resonance imaging.
    Ichikawa H; Ishikawa M; Fukunaga M; Ishikawa K; Ishiyama H
    Brain Res; 2010 Mar; 1321():125-32. PubMed ID: 20114032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversals of blood-brain barrier disruption by catalase: a serial magnetic resonance imaging study of experimental optic neuritis.
    Guy J; McGorray S; Fitzsimmons J; Beck B; Mancuso A; Rao NA; Hamed L
    Invest Ophthalmol Vis Sci; 1994 Aug; 35(9):3456-65. PubMed ID: 8056521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Changes in tissue T1 of brain tumor following GD-DTPA administration--differences in T1 time course and tissue-blood ratio by histological types].
    Yoshida K; Furuse M; Kaneoke Y; Sasou K; Motegi Y
    No To Shinkei; 1988 Jun; 40(6):531-7. PubMed ID: 3224029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transient widespread blood-brain barrier alterations after cerebral photothrombosis as revealed by gadofluorine M-enhanced magnetic resonance imaging.
    Stoll G; Kleinschnitz C; Meuth SG; Braeuninger S; Ip CW; Wessig C; Nölte I; Bendszus M
    J Cereb Blood Flow Metab; 2009 Feb; 29(2):331-41. PubMed ID: 18957988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MR molecular imaging of early endothelial activation in focal ischemia.
    Barber PA; Foniok T; Kirk D; Buchan AM; Laurent S; Boutry S; Muller RN; Hoyte L; Tomanek B; Tuor UI
    Ann Neurol; 2004 Jul; 56(1):116-20. PubMed ID: 15236408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential of gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid (Gd-EOB-DTPA) for differential diagnosis of nonalcoholic steatohepatitis and fatty liver in rats using magnetic resonance imaging.
    Tsuda N; Okada M; Murakami T
    Invest Radiol; 2007 Apr; 42(4):242-7. PubMed ID: 17351431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of BBB disruption and hemorrhage by Gd-DTPA enhanced MRI after embolic stroke in rat.
    Ding G; Jiang Q; Li L; Zhang L; Gang Zhang Z; Ledbetter KA; Ewing JR; Li Q; Chopp M
    Brain Res; 2006 Oct; 1114(1):195-203. PubMed ID: 16950236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gadolinium-DTPA enhancement of VX-2 carcinoma of the rabbit kidney on T1 weighted magnetic resonance images.
    Yancey JM; Ackerman N; Kaude JV; Googe RE; Fitzsimmons JR; Scott KN; Mancuso AA; Hackett RL; Hager DA; Caballero S
    Acta Radiol; 1987; 28(4):479-82. PubMed ID: 2958067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic resonance imaging with gadolinium-DTPA for detecting cardiac transplant rejection in rats.
    Konstam MA; Aronovitz MJ; Runge VM; Kaufman DM; Brockway BA; Isner JM; Katzen NA; Dresdale AR; Diehl JT; Kaplan E
    Circulation; 1988 Nov; 78(5 Pt 2):III87-94. PubMed ID: 3052922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative magnetic resonance imaging of rat brain tumors: in vivo NMR relaxometry for the discrimination of normal and pathological tissues.
    Hoehn-Berlage M; Bockhorst K
    Technol Health Care; 1994 Dec; 2(4):247-54. PubMed ID: 7842309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of kainate toxicity using contrast enhanced magnetic resonance imaging.
    Beravs K; Frangez R; Demsar F
    Pflugers Arch; 2000; 440(5 Suppl):R153-4. PubMed ID: 11005651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MR contrast enhancement of intracranial lesions with Gd-DTPA.
    Hesselink JR; Press GA
    Radiol Clin North Am; 1988 Jul; 26(4):873-87. PubMed ID: 3289078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-ischemic blood-brain barrier leakage in rats: one-week follow-up by MRI.
    Durukan A; Marinkovic I; Strbian D; Pitkonen M; Pedrono E; Soinne L; Abo-Ramadan U; Tatlisumak T
    Brain Res; 2009 Jul; 1280():158-65. PubMed ID: 19450568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative magnetic resonance imaging in assessment of the blood-retinal barrier.
    Plehwe WE; McRobbie DW; Lerski RA; Kohner EM
    Invest Ophthalmol Vis Sci; 1988 May; 29(5):663-70. PubMed ID: 3366561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Role of Gadolinium-DTPA in the assessment of renal tumors with magnetic resonance].
    Torricelli P; Montanari N; De Santis M; Pollastri C
    Radiol Med; 1994 May; 87(5):653-61. PubMed ID: 8008898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of gadolinium-DTPA as a myocardial perfusion agent: potential applications and limitations for magnetic resonance imaging.
    Johnston DL; Liu P; Lauffer RB; Newell JB; Wedeen VJ; Rosen BR; Brady TJ; Okada RD
    J Nucl Med; 1987 May; 28(5):871-7. PubMed ID: 3572546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.